{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:32:03Z","timestamp":1786991523465,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS120704"],"award-info":[{"award-number":["NS120704"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS125769"],"award-info":[{"award-number":["NS125769"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS118859"],"award-info":[{"award-number":["NS118859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jbc.2024.107660","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T21:26:16Z","timestamp":1723497976000},"page":"107660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["TDP43 and huntingtin Exon-1 undergo a conformationally specific interaction that strongly alters the fibril formation of both proteins"],"prefix":"10.1016","volume":"300","author":[{"given":"Gincy","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anakha","family":"Ajayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobin","family":"Varkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-4090","authenticated-orcid":false,"given":"Nitin K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Langen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107660_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.jbc.2024.107660_bib2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","article-title":"CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion","volume":"78","author":"Lee","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2024.107660_bib3","first-page":"689","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann. Neurol. Official J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.jbc.2024.107660_bib4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A\u00a0worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.107660_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107660_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington\u2019s disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosciences"},{"key":"10.1016\/j.jbc.2024.107660_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington\u2019s disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jbc.2024.107660_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2024.107660_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin\u2013proteasome system activity in the synapses of Huntington's disease mice","volume":"180","author":"Wang","year":"2008","journal-title":"J.\u00a0Cel. Biol."},{"key":"10.1016\/j.jbc.2024.107660_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107660_bib11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","article-title":"Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation","volume":"12","author":"Waelter","year":"2001","journal-title":"Mol. Biol. Cel."},{"key":"10.1016\/j.jbc.2024.107660_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104720","article-title":"Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease","volume":"94","author":"Tano","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2024.107660_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neures.2009.10.004","article-title":"The RNA-binding protein FUS\/TLS is a common aggregate-interacting protein in polyglutamine diseases","volume":"66","author":"Doi","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jbc.2024.107660_bib14","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107660_bib15","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107660_bib16","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib17","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jbc.2024.107660_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. biophysical Res. Commun."},{"key":"10.1016\/j.jbc.2024.107660_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107660_bib20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2024.107660_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","article-title":"Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"173","author":"Igaz","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2024.107660_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","article-title":"Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis","volume":"30","author":"Barmada","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2024.107660_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuron.2020.11.005","article-title":"Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis","volume":"109","author":"Dewan","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.107660_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107660_bib25","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/hmg\/ddr045","article-title":"Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients","volume":"20","author":"Lee","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107660_bib26","doi-asserted-by":"crossref","first-page":"fcaa064","DOI":"10.1093\/braincomms\/fcaa064","article-title":"ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization","volume":"2","author":"Tazelaar","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.jbc.2024.107660_bib27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.21937","article-title":"Genetically confirmed Huntington's disease masquerading as motor neuron disease","volume":"23","author":"Kanai","year":"2008","journal-title":"Movement Disord."},{"key":"10.1016\/j.jbc.2024.107660_bib28","first-page":"1649","article-title":"Association of genetically proven Huntington\u2019s disease and sporadic amyotrophic lateral sclerosis in a 72-year-old woman","volume":"253","author":"Papageorgiou","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jbc.2024.107660_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/17482960903055958","article-title":"Huntington's disease presenting as amyotrophic lateral sclerosis","volume":"11","author":"Phukan","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jbc.2024.107660_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s004010050539","article-title":"Coexistence of Huntington\u2019s disease and familial amyotrophic lateral sclerosis: case presentation","volume":"92","author":"Rubio","year":"1996","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.jbc.2024.107660_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archneurol.2011.76","article-title":"Huntington chorea presenting with motor neuron disease","volume":"68","author":"Sadeghian","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jbc.2024.107660_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140723","article-title":"Huntington\u2019s disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization","volume":"131","author":"Sanchez","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2024.107660_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jbc.2024.107660_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","article-title":"Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study","volume":"124","author":"Tada","year":"2012","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.jbc.2024.107660_bib35","article-title":"Aberrant splicing in Huntington's disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification","volume":"2","author":"Nguyen","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2024.107660_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nchembio.694","article-title":"Identifying polyglutamine protein species in situ that best predict neurodegeneration","volume":"7","author":"Miller","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107660_bib37","doi-asserted-by":"crossref","first-page":"31739","DOI":"10.1074\/jbc.M112.353839","article-title":"Structural features and domain organization of huntingtin fibrils","volume":"287","author":"Bugg","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib38","doi-asserted-by":"crossref","first-page":"19613","DOI":"10.1074\/jbc.RA118.004808","article-title":"The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract","volume":"293","author":"Bravo-Arredondo","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib39","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1074\/jbc.M117.813667","article-title":"The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms","volume":"293","author":"Pandey","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib40","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jmb.2018.03.031","article-title":"Tadpole-like conformations of huntingtin exon 1 are characterized by conformational heterogeneity that persists regardless of polyglutamine length","volume":"430","author":"Newcombe","year":"2018","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107660_bib41","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1073\/pnas.1521933113","article-title":"Huntingtin exon 1 fibrils feature an interdigitated \u03b2-hairpin\u2013based polyglutamine core","volume":"113","author":"Hoop","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15462","article-title":"Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107660_bib43","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/ja110715f","article-title":"The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils","volume":"133","author":"Sivanandam","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107660_bib44","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-021-24411-2","article-title":"Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted","volume":"12","author":"Mario Isas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107660_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol. Cel."},{"key":"10.1016\/j.jbc.2024.107660_bib46","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molcel.2016.07.022","article-title":"Soluble oligomers of PolyQ-expanded huntingtin target a multiplicity of key cellular factors","volume":"63","author":"Kim","year":"2016","journal-title":"Mol. Cel."},{"key":"10.1016\/j.jbc.2024.107660_bib47","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107660_bib48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107660_bib49","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1073\/pnas.0812083106","article-title":"Distinct conformations of in\u00a0vitro and in\u00a0vivo amyloids of huntingtin-exon1 show different cytotoxicity","volume":"106","author":"Nekooki-Machida","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2014.01.007","article-title":"Structural characterization of the minimal segment of TDP-43 competent for aggregation","volume":"545","author":"Mompe\u00e1n","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2024.107660_bib51","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.str.2016.07.007","article-title":"ALS mutations disrupt phase separation mediated by \u03b1-helical structure in the TDP-43 low-complexity C-terminal domain","volume":"24","author":"Conicella","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2024.107660_bib52","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900489","article-title":"The huntingtin inclusion is a dynamic phase-separated compartment","volume":"2","author":"Aktar","year":"2019","journal-title":"Life Sci. alliance"},{"key":"10.1016\/j.jbc.2024.107660_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molcel.2018.04.007","article-title":"A\u00a0liquid to solid phase transition underlying pathological huntingtin exon1 aggregation","volume":"7070","author":"Peskett","year":"2018","journal-title":"Mol. Cel."},{"key":"10.1016\/j.jbc.2024.107660_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105585","article-title":"Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1","volume":"300","author":"Pandey","year":"2024","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib55","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1074\/jbc.RA118.007222","article-title":"The role of liquid\u2013liquid phase separation in aggregation of the TDP-43 low-complexity domain","volume":"294","author":"Babinchak","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib56","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbapap.2017.10.001","article-title":"The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43","volume":"1866","author":"Li","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteomics"},{"key":"10.1016\/j.jbc.2024.107660_bib57","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41422-021-00526-5","article-title":"Hsp70 chaperones TDP-43 in dynamic, liquid-like phase and prevents it from amyloid aggregation","volume":"31","author":"Gu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2024.107660_bib58","doi-asserted-by":"crossref","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","article-title":"Interaction with polyglutamine aggregates reveals a Q\/N-rich domain in TDP-43","volume":"285","author":"Fuentealba","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib59","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3390\/ijms23073950","article-title":"Expression of Huntingtin and TDP-43 derivatives in fission yeast can cause both beneficial and toxic effects","volume":"23","author":"Marte","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib60","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s00018-019-03059-8","article-title":"Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models","volume":"76","author":"Coudert","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib61","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1038\/s41467-021-26684-z","article-title":"Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties","volume":"12","author":"Riguet","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107660_bib62","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1093\/hmg\/ddy141","article-title":"Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin","volume":"27","author":"Ko","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107660_bib63","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","article-title":"A\u00a0liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation","volume":"162","author":"Patel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107660_bib64","doi-asserted-by":"crossref","first-page":"12050","DOI":"10.1073\/pnas.1916716117","article-title":"Liquid\u2013liquid phase separation of type II diabetes-associated IAPP initiates hydrogelation and aggregation","volume":"117","author":"Pytowski","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib65","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid\u2013liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107660_bib66","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.biochem.6b01088","article-title":"Phase to phase with TDP-43","volume":"56","author":"Sun","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107660_bib67","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.3390\/ijms22158213","article-title":"The different faces of the TDP-43 Low-complexity domain: the formation of liquid droplets and amyloid fibrils","volume":"22","author":"Chien","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108113","article-title":"Molecular mechanism of the inhibition of TDP-43 amyloidogenesis by QBP1","volume":"675","author":"Mompean","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2024.107660_bib69","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00401-009-0552-x","article-title":"Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado\u2013Joseph disease","volume":"118","author":"Tan","year":"2009","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.jbc.2024.107660_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/neup.12053","article-title":"TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis","volume":"34","author":"Toyoshima","year":"2014","journal-title":"Neuropathology"},{"key":"10.1016\/j.jbc.2024.107660_bib71","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/hmg\/dds485","article-title":"Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models","volume":"22","author":"Tauffenberger","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.107660_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111106","article-title":"Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export","volume":"40","author":"Duan","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2024.107660_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. neurodegeneration"},{"key":"10.1016\/j.jbc.2024.107660_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2023.102484","article-title":"Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington\u2019s disease knock-in mice","volume":"227","author":"Bai","year":"2023","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jbc.2024.107660_bib75","doi-asserted-by":"crossref","first-page":"e3002527","DOI":"10.1371\/journal.pbio.3002527","article-title":"RNA-mediated ribonucleoprotein assembly controls TDP-43 nuclear retention","volume":"22","author":"Dos Passos","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jbc.2024.107660_bib76","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41586-023-06701-5","article-title":"m1A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration","volume":"623","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107660_bib77","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153632","article-title":"Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties","volume":"22","author":"Grese","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2024.107660_bib78","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s42003-023-05608-1","article-title":"\u03b1-Synuclein emulsifies TDP-43 prion-like domain\u2014RNA liquid droplets to promote heterotypic amyloid fibrils","volume":"6","author":"Dhakal","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2024.107660_bib79","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7150\/ijbs.7.234","article-title":"TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice","volume":"7","author":"Tian","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jbc.2024.107660_bib80","article-title":"Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43, drive ribonucleoprotein condensate transport dysfunction and suppress local translation","volume":"15","author":"Wijegunawardana","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2024.107660_bib81","doi-asserted-by":"crossref","first-page":"41310","DOI":"10.1074\/jbc.M112.398099","article-title":"Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS)","volume":"287","author":"Nihei","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107660_bib82","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","article-title":"Staging TDP-43 pathology in Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta neuropathologica"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824021616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824021616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T19:39:01Z","timestamp":1734377941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824021616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0021925824021616"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107660","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TDP43 and huntingtin Exon-1 undergo a conformationally specific interaction that strongly alters the fibril formation of both proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107660"}}